RxDoctor Payments Data

Priya Vasdev, MD

Geriatric Medicine · Bowie, MDNPI 1942221197

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations.

$886in general payments, 2019–2025

Across 43 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$167
  • Otsuka America Pharmaceutical, Inc.$146
  • Novo Nordisk$123
  • Amgen$97
  • Pfizer$53
  • Acadia Pharmaceuticals Inc$47
  • plus $255 from 10 others

What the payments were for

  • Food & beverage$886100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$886 in reported general payments places this provider in the 70th percentile of 112 geriatric medicine providers in Maryland.

See all geriatric medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$238,700
Medicare patients
403
Services billed
2,511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban347$177,181
XareltoRivaroxaban38$24,276
NuedextaDextromethorphan Hbr/Quinidine12$16,677
JanuviaSitagliptin Phosphate33$15,761
JardianceEmpagliflozin34$14,003
EntrestoSacubitril/Valsartan17$12,762
MyrbetriqMirabegron25$11,711
RytaryCarbidopa/Levodopa29$11,289
TrulicityDulaglutide19$9,878
Breo ElliptaFluticasone/Vilanterol18$7,729
SantylCollagenase Clostridium Hist.12$7,309
BrilintaTicagrelor26$7,101
Atorvastatin Calcium305$5,803
Mirtazapine198$5,731
Lansoprazole18$5,528

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$53$177,181347 claims
Johnson & JohnsonXarelto$38$24,27638 claims
Avanir Pharmaceuticals, Inc.Nuedexta$24$16,67712 claims
NovartisEntresto$167$12,76217 claims
Lilly USA, LLCTrulicity$16$9,87819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 112 geriatric medicine providers in Maryland.

Other geriatric medicine in Bowie

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →